175 related articles for article (PubMed ID: 16378600)
1. Human CC chemokine CCL23 enhances expression of matrix metalloproteinase-2 and invasion of vascular endothelial cells.
Son KN; Hwang J; Kwon BS; Kim J
Biochem Biophys Res Commun; 2006 Feb; 340(2):498-504. PubMed ID: 16378600
[TBL] [Abstract][Full Text] [Related]
2. Human CC chemokine CCL23, a ligand for CCR1, induces endothelial cell migration and promotes angiogenesis.
Hwang J; Son KN; Kim CW; Ko J; Na DS; Kwon BS; Gho YS; Kim J
Cytokine; 2005 Jun; 30(5):254-63. PubMed ID: 15927850
[TBL] [Abstract][Full Text] [Related]
3. CCL23 up-regulates expression of KDR/Flk-1 and potentiates VEGF-induced proliferation and migration of human endothelial cells.
Han KY; Kim CW; Lee TH; Son Y; Kim J
Biochem Biophys Res Commun; 2009 Apr; 382(1):124-8. PubMed ID: 19265684
[TBL] [Abstract][Full Text] [Related]
4. Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model.
Karagiannis ED; Popel AS
J Theor Biol; 2006 Jan; 238(1):124-45. PubMed ID: 16005020
[TBL] [Abstract][Full Text] [Related]
5. Elastin-derived peptides enhance angiogenesis by promoting endothelial cell migration and tubulogenesis through upregulation of MT1-MMP.
Robinet A; Fahem A; Cauchard JH; Huet E; Vincent L; Lorimier S; Antonicelli F; Soria C; Crepin M; Hornebeck W; Bellon G
J Cell Sci; 2005 Jan; 118(Pt 2):343-56. PubMed ID: 15632106
[TBL] [Abstract][Full Text] [Related]
6. Role of metalloproteinases MMP-9 and MT1-MMP in CXCL12-promoted myeloma cell invasion across basement membranes.
Parmo-Cabañas M; Molina-Ortiz I; Matías-Román S; García-Bernal D; Carvajal-Vergara X; Valle I; Pandiella A; Arroyo AG; Teixidó J
J Pathol; 2006 Jan; 208(1):108-18. PubMed ID: 16278822
[TBL] [Abstract][Full Text] [Related]
7. Anti-angiogenic effects of a nutrient mixture on human umbilical vein endothelial cells.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Oncol Rep; 2005 Dec; 14(6):1399-404. PubMed ID: 16273231
[TBL] [Abstract][Full Text] [Related]
8. Anti-angiogenic effect of Tanshinone IIA involves inhibition of matrix invasion and modification of MMP-2/TIMP-2 secretion in vascular endothelial cells.
Tsai MY; Yang RC; Wu HT; Pang JH; Huang ST
Cancer Lett; 2011 Nov; 310(2):198-206. PubMed ID: 21788102
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 epoxygenases 2C8 and 2C9 are implicated in hypoxia-induced endothelial cell migration and angiogenesis.
Michaelis UR; Fisslthaler B; Barbosa-Sicard E; Falck JR; Fleming I; Busse R
J Cell Sci; 2005 Dec; 118(Pt 23):5489-98. PubMed ID: 16291720
[TBL] [Abstract][Full Text] [Related]
10. Opposite effects of high glucose on MMP-2 and TIMP-2 in human endothelial cells.
Ho FM; Liu SH; Lin WW; Liau CS
J Cell Biochem; 2007 May; 101(2):442-50. PubMed ID: 17203468
[TBL] [Abstract][Full Text] [Related]
11. In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues.
Tondreau T; Meuleman N; Stamatopoulos B; De Bruyn C; Delforge A; Dejeneffe M; Martiat P; Bron D; Lagneaux L
Cytotherapy; 2009; 11(5):559-69. PubMed ID: 19551542
[TBL] [Abstract][Full Text] [Related]
12. EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture.
Schmidt R; Redecke V; Breitfeld Y; Wantia N; Miethke T; Massberg S; Fischel S; Neumann FJ; Schömig A; May AE
Thromb Haemost; 2006 Jan; 95(1):151-8. PubMed ID: 16543974
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-2 (MMP-2) expression and regulation by tumor necrosis factor alpha (TNFalpha) in the bovine corpus luteum.
Zhang B; Yan L; Tsang PC; Moses MA
Mol Reprod Dev; 2005 Feb; 70(2):122-32. PubMed ID: 15570615
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy.
Benelli R; Adatia R; Ensoli B; Stetler-Stevenson WG; Santi L; Albini A
Oncol Res; 1994; 6(6):251-7. PubMed ID: 7532474
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases of human NK cells.
Albertsson P; Kim MH; Jonges LE; Kitson RP; Kuppen PJ; Johansson BR; Nannmark U; Goldfarb RH
In Vivo; 2000; 14(1):269-76. PubMed ID: 10757086
[TBL] [Abstract][Full Text] [Related]
16. Nafoxidine modulates the expression of matrix-metalloproteinase-2 (MMP-2) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in endothelial cells.
De Lorenzo MS; Alonso DF; Gomez DE
Anticancer Res; 2000; 20(1A):395-400. PubMed ID: 10769686
[TBL] [Abstract][Full Text] [Related]
17. Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP-12-dependent cleavage of the endothelial cell urokinase receptor.
Serratì S; Cinelli M; Margheri F; Guiducci S; Del Rosso A; Pucci M; Fibbi G; Bazzichi L; Bombardieri S; Matucci-Cerinic M; Del Rosso M
J Pathol; 2006 Oct; 210(2):240-8. PubMed ID: 16917801
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1.
Ramer R; Hinz B
J Natl Cancer Inst; 2008 Jan; 100(1):59-69. PubMed ID: 18159069
[TBL] [Abstract][Full Text] [Related]
19. Brain-derived neurotrophic factor inducing angiogenesis through modulation of matrix-degrading proteases.
Sun CY; Hu Y; Wang HF; He WJ; Wang YD; Wu T
Chin Med J (Engl); 2006 Apr; 119(7):589-95. PubMed ID: 16620701
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide inhibits matrix metalloproteinase-2 expression via the induction of activating transcription factor 3 in endothelial cells.
Chen HH; Wang DL
Mol Pharmacol; 2004 May; 65(5):1130-40. PubMed ID: 15102941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
